Form D · Other
SciAps Inc
Woburn, MA · CIK 0001570867
Offering snapshot reported Jul 21, 2023 · SEC filing
- Reported sold
- $5.09M Offering amount: $5.09M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 14, 2023 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$3,965,330 → $5,090,330
- Reported investors2 → 6
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 21, 2023 | Amendment | $5,090,330 | $1,125,000vs May 3, 2023 | 6 | SEC filing |
| May 3, 2023 | Initial | $3,965,330 | No comparison | 2 | SEC filing |
| Jan 17, 2023 | Amendment | $6,587,500 | $2,097,500vs Mar 25, 2021 | 12 | SEC filing |
| Aug 27, 2021 | Initial | $7,219,992 | No comparison | Not reported | SEC filing |
| Mar 25, 2021 | Amendment | $4,490,000 | $1,490,000vs Apr 30, 2020 | 6 | SEC filing |
| Apr 30, 2020 | Initial | $3,000,000 | No comparison | 3 | SEC filing |
| Apr 25, 2019 | Initial | $12,500,000 | No comparison | 11 | SEC filing |
| Mar 12, 2018 | Initial | $7,370,940 | No comparison | 11 | SEC filing |
| Apr 7, 2017 | Initial | $1,940,186 | No comparison | 9 | SEC filing |
| Sep 23, 2016 | Initial | $1,593,079 | No comparison | 5 | SEC filing |
| Apr 15, 2016 | Initial | $1,043,179 | No comparison | 4 | SEC filing |
| Sep 1, 2015 | Initial | $4,300,003 | No comparison | 7 | SEC filing |
| May 20, 2015 | Initial | $3,117,548 | No comparison | 10 | SEC filing |
| Nov 25, 2013 | Initial | $2,584,224 | No comparison | 5 | SEC filing |
| Jul 19, 2013 | Amendment | $2,816,962 | $1,300,000vs Mar 4, 2013 | 12 | SEC filing |
| Jul 19, 2013 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Mar 4, 2013 | Initial | $1,516,962 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $238K
- Finders' fees
- $25K (estimated)
- Form D file number
- 021-480660
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| U.S. Boston Capital Corporation | 5251 |
Source: Form D, filed Jul 21, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Burke | Director |
| William Clarke | Director |
| Christopher F. Davis | Director |
| David Day | Director |
| Charles Gillies | Director |
| Gary A. Lortie | Executive |
| John Mc Clellan | Director |
| Mohamed Ousseimi | Director |
| Daniel Penberthy | Director |
| Robert Porell | Director |
| Donald W. Sackett | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
7 Constitution Way
Woburn, MA, 01801
Woburn, MA, 01801